ADAG

MKT CAP:$262M

Adagene Inc

Market Cap

$262M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.32+$1.48 (+80.43%)

Jun 5, 2026

52W High $4.6152W Low $1.41

Company Details

Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-...

CEO

—

IPO Date

Feb 9, 2021

Website

www.adagene.com

Key Metrics TTM

Revenue

$8M

+855.7% YoY

Net Income

-$51M

EPS (Diluted)

Free Cash Flow

-$45M

Revenue / Share

$0.21

Gross Margin

80.6%

Operating Margin

-736.8%

Net Margin

-655.2%

FCF Margin

-583.0%

P/S

33.6x

P/E

Earnings Reports

Q1 2026

Apr 1, 2026

$8M

FY 2025

Apr 1, 2026

$8M+7332.8%

Q2 2025

Aug 12, 2025

FY 2024

Mar 24, 2025

$103.2K-99.4%

Q4 2024

Mar 24, 2025

$103.2K-74.7%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee